Delcath Systems Inc (DCTH)

[ash111]

DCTH That's why you do due diligence. When you know what you have, you don't mind waiting, you just want to make sure you are in when it goes, as you'll never time it perfectly. hot February. 2 presentations, we know the dates, more safer. no sudden surprises.

Ocular Melanoma- Phase 3

Hepatocellular Carcinoma (HCC)- Phase 2

Intrahepatic Cholangiocarcinoma (ICC)- Phase 2

CE Mark + six orphan drug Approval

2.2m O/S a/o today. on more 10m, 20m shares, cap is $5m-$10. now compare it to industry.